Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 3
2004 3
2005 6
2006 3
2007 5
2008 1
2009 5
2010 3
2011 3
2012 5
2013 9
2014 3
2015 5
2016 3
2017 3
2018 6
2019 5
2020 5
Text availability
Article attribute
Article type
Publication date

Search Results

73 results
Results by year
Filters applied: . Clear all
Page 1
The epidermal growth factor receptor variant III (EGFRvIII): where wild things are altered.
Gan HK, Cvrljevic AN, Johns TG. Gan HK, et al. Among authors: johns tg. FEBS J. 2013 Nov;280(21):5350-70. doi: 10.1111/febs.12393. Epub 2013 Jul 8. FEBS J. 2013. PMID: 23777544 Free article. Review.
A reference collection of patient-derived cell line and xenograft models of proneural, classical and mesenchymal glioblastoma.
Stringer BW, Day BW, D'Souza RCJ, Jamieson PR, Ensbey KS, Bruce ZC, Lim YC, Goasdoué K, Offenhäuser C, Akgül S, Allan S, Robertson T, Lucas P, Tollesson G, Campbell S, Winter C, Do H, Dobrovic A, Inglis PL, Jeffree RL, Johns TG, Boyd AW. Stringer BW, et al. Among authors: johns tg. Sci Rep. 2019 Mar 20;9(1):4902. doi: 10.1038/s41598-019-41277-z. Sci Rep. 2019. PMID: 30894629 Free PMC article.
The dystroglycan receptor maintains glioma stem cells in the vascular niche.
Day BW, Lathia JD, Bruce ZC, D'Souza RCJ, Baumgartner U, Ensbey KS, Lim YC, Stringer BW, Akgül S, Offenhäuser C, Li Y, Jamieson PR, Smith FM, Jurd CLR, Robertson T, Inglis PL, Lwin Z, Jeffree RL, Johns TG, Bhat KPL, Rich JN, Campbell KP, Boyd AW. Day BW, et al. Among authors: johns tg. Acta Neuropathol. 2019 Dec;138(6):1033-1052. doi: 10.1007/s00401-019-02069-x. Epub 2019 Aug 28. Acta Neuropathol. 2019. PMID: 31463571 Free PMC article.
Whole genome and biomarker analysis of patients with recurrent glioblastoma on bevacizumab: A subset analysis of the CABARET trial.
Olafson LR, Siddell AH, Field KM, Byrnes M, Rapkins RW, Ng B, Nixdorf S, Barnes EH, Johns TG, Yip S, Simes J, Nowak AK, Rosenthal MA, McDonald KL. Olafson LR, et al. Among authors: johns tg. J Clin Neurosci. 2019 Dec;70:157-163. doi: 10.1016/j.jocn.2019.08.044. Epub 2019 Sep 30. J Clin Neurosci. 2019. PMID: 31582283
Most clinical anti-EGFR antibodies do not neutralize both wtEGFR and EGFRvIII activation in glioma.
Greenall SA, McKenzie M, Seminova E, Dolezal O, Pearce L, Bentley J, Kuchibhotla M, Chen SC, McDonald KL, Kornblum H, Endersby R, Adams TE, Johns TG. Greenall SA, et al. Among authors: johns tg. Neuro Oncol. 2019 Apr 19;21(8):1016-27. doi: 10.1093/neuonc/noz073. Online ahead of print. Neuro Oncol. 2019. PMID: 31002307 Free PMC article.
EGFRvIII: the promiscuous mutation.
Greenall SA, Johns TG. Greenall SA, et al. Among authors: johns tg. Cell Death Discov. 2016 Jul 4;2:16049. doi: 10.1038/cddiscovery.2016.49. eCollection 2016. Cell Death Discov. 2016. PMID: 27551537 Free PMC article. No abstract available.
DYRK1A in neurodegeneration and cancer: Molecular basis and clinical implications.
Abbassi R, Johns TG, Kassiou M, Munoz L. Abbassi R, et al. Among authors: johns tg. Pharmacol Ther. 2015 Jul;151:87-98. doi: 10.1016/j.pharmthera.2015.03.004. Epub 2015 Mar 17. Pharmacol Ther. 2015. PMID: 25795597 Review.
Activation of ERBB4 in Glioblastoma Can Contribute to Increased Tumorigenicity and Influence Therapeutic Response.
Donoghue JF, Kerr LT, Alexander NW, Greenall SA, Longano AB, Gottardo NG, Wang R, Tabar V, Adams TE, Mischel PS, Johns TG. Donoghue JF, et al. Among authors: johns tg. Cancers (Basel). 2018 Jul 25;10(8):243. doi: 10.3390/cancers10080243. Cancers (Basel). 2018. PMID: 30044378 Free PMC article.
Targeting the ERBB family in cancer: couples therapy.
Tebbutt N, Pedersen MW, Johns TG. Tebbutt N, et al. Among authors: johns tg. Nat Rev Cancer. 2013 Sep;13(9):663-73. doi: 10.1038/nrc3559. Epub 2013 Aug 16. Nat Rev Cancer. 2013. PMID: 23949426 Review.
Changes in cell morphology guide identification of tubulin as the off-target for protein kinase inhibitors.
Hoque M, Abbassi RH, Froio D, Man J, Johns TG, Stringer BW, Day BW, Pajic M, Kassiou M, Munoz L. Hoque M, et al. Among authors: johns tg. Pharmacol Res. 2018 Aug;134:166-178. doi: 10.1016/j.phrs.2018.06.023. Epub 2018 Jun 23. Pharmacol Res. 2018. PMID: 29944980
73 results
Jump to page
Feedback